ICICI Prudential Asset Management Co Ltd reduced its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 77.0% during the 3rd quarter, Holdings Channel reports. The firm owned 2,841 shares of the semiconductor company’s stock after selling 9,503 shares during the quarter. ICICI Prudential Asset Management Co Ltd’s holdings in Synopsys were worth $1,402,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in the business. Stanley Laman Group Ltd. raised its holdings in shares of Synopsys by 542.9% during the third quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock valued at $6,353,000 after acquiring an additional 10,874 shares during the last quarter. Symphony Financial Ltd. Co. increased its position in shares of Synopsys by 4,780.9% during the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after purchasing an additional 39,395 shares in the last quarter. Bank of New York Mellon Corp raised its stake in Synopsys by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after purchasing an additional 4,815 shares during the last quarter. Waverton Investment Management Ltd lifted its holdings in Synopsys by 15.0% in the 2nd quarter. Waverton Investment Management Ltd now owns 578,299 shares of the semiconductor company’s stock valued at $296,630,000 after purchasing an additional 75,374 shares in the last quarter. Finally, Motley Fool Asset Management LLC grew its holdings in shares of Synopsys by 13.4% during the second quarter. Motley Fool Asset Management LLC now owns 9,757 shares of the semiconductor company’s stock worth $5,002,000 after buying an additional 1,156 shares in the last quarter. 85.47% of the stock is owned by institutional investors and hedge funds.
Synopsys Price Performance
SNPS stock opened at $442.44 on Friday. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The stock has a market cap of $84.65 billion, a price-to-earnings ratio of 55.37, a price-to-earnings-growth ratio of 3.68 and a beta of 1.12. The business has a fifty day moving average of $474.32 and a two-hundred day moving average of $485.28.
Wall Street Analysts Forecast Growth
SNPS has been the topic of several research reports. Piper Sandler downgraded shares of Synopsys from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $602.00 to $520.00 in a research note on Tuesday, January 13th. Morgan Stanley raised their target price on shares of Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. Wells Fargo & Company upped their price target on Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a research report on Thursday, December 11th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $560.00 price target on shares of Synopsys in a report on Friday. Finally, Wall Street Zen raised Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Synopsys presently has an average rating of “Moderate Buy” and an average target price of $553.57.
View Our Latest Research Report on Synopsys
Insider Transactions at Synopsys
In related news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares in the company, valued at approximately $6,338,270. The trade was a 2.05% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 4,157 shares of company stock valued at $1,945,036. Company insiders own 0.62% of the company’s stock.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- 3 Signs You May Want to Switch Financial Advisors
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- NEW LAW: Congress Approves Setup For Digital Dollar?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
